How to Ensure That You Receive Full and Fair Compensation for Your Empagliflozin (Jardiance) Amputation
Prescription Jardiance has been linked to amputation injuries in patients who took the drug to treat their type 2 diabetes. Parker Waichman LLP is pursuing litigation against the manufacturers of Jardiance to obtain significant compensation on behalf of victims and their families. If you took Jardiance and underwent amputation of your toes, feet, or legs, contact Parker Waichman LLP to talk to one of our compassionate drug product attorneys about your potential for filing a lawsuit.
Who Manufactures Jardiance (empagliflozin)?
Jardiance (empagliflozin) is manufactured by Boehringer Ingelheim and Eli Lilly and is part of a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. The drug, which has been on the market since August 2014, targets a specific protein in the body to help patients establish control of their blood sugar.
Studies Show SGLT2 Inhibitor, such as ‘Jardiance’, Increase the Risk of Leg Amputations
But Jardiance can cause diabetic patients to develop serious medical conditions that lead to horrific amputations. Studies of SGLT2 inhibitors have shown a two-times greater risk of amputations when compared to patients taking a placebo. Patients most commonly suffer amputations of their toes and portions of their feet, but many patients have also been forced to undergo amputations of their legs.
Both the FDA & European Medical Agency (EMA) Issues Warnings
The FDA has already mandated warnings regarding amputation risks on at least one SGLT2 inhibitor, and the European Medical Agency (EMA) issued further warnings that include ‘Jardiance’. Parker Waichman LLP is fighting for U.S. manufacturers to change their drug labels, as well, or pull these dangerous drugs off the market. Our firm recently made national news for filing lawsuits on behalf of people devastated by amputations, and we are one of only a few law firms to secure more than $2 billion in compensation for our clients.
If you have or someone you love has been harmed by the defective drug Jardiance, contact Parker Waichman LLP to find out if you are eligible to join our active case litigation.
Frequently Asked Questions About Jardiance Amputation Lawsuits
At Parker Waichman LLP we want to make sure our clients always have the most accurate, up-to-date information about their cases and the overall litigation surrounding the drug products that injured them. Below you will find some questions we often hear from our new Jardiance clients, along with our answers containing the latest information available about the drug.
How does Jardiance work for treating type 2 diabetes?
Jardiance is designed to allow your kidneys to expel glucose through urine. In your body’s ordinary function, a protein in your body (the SGLT2 protein) allows glucose to be re-absorbed during the waste process so that your body can use the glucose for energy. Diabetic patients who already struggle with high glucose do not need this re-absorption process to take place, so Jardiance inhibits the protein that makes it possible.
Has the FDA recalled Jardiance?
No, Jardiance has not been recalled. The FDA approved the drug in 2014 for treatment of type 2 diabetes and recently expanded approved uses of the drug to include cardiovascular disease in patients with type 2 diabetes. However, the FDA has required a black box warning on at least one SGLT2 inhibitor (Invokana) regarding an increased risk of amputations. A black box warning is the strongest warning that can be placed on a prescription drug and requires that severe warning information is featured at the top of the drug label inside a bold black box. The FDA required this warning after two drug trials showed a 50 percent increase in amputations among patients taking the SGLT2 inhibitor versus patients taking a placebo.
Will I be part of a Jardiance class action?
At this time, we are pursuing Jardiance lawsuits as part of a mass tort, not a class action. One of the most significant differences between these two types of litigation is the petitions. In a class action, all members of the “class” are part of the same petition that features only a handful of named plaintiffs. In a mass tort, every plaintiff has his or her own lawsuit. A separate petition is filed for each plaintiff in a mass tort, rather than one comprehensive petition for everyone. Many of our clients prefer mass torts because of the opportunity to have their own lawsuits that tell their individual stories.
Parker Waichman LLP is Reviewing Jardiance Cases
Our nationally recognized firm is currently reviewing Jardiance cases on behalf of people who have suffered devastating amputation injuries. We are now offering free, no-obligation case consultations for Jardiance clients and are contracting these cases on a contingency fee basis. When you sign up with a contingency fee contract, our recovery is dependent on your own. If you don’t get paid for your claims, we won’t get paid, either. Because we take on all the financial risk, there has never been a better time to protect your rights. Contact Parker Waichman LLP today to speak with one of our skilled Jardiance attorneys about your potential claim.
Contact Parker Waichman LLP
You deserve the best legal representation during this tough time, and Parker Waichman LLP will fight for the compensation you need. If you or a loved one took ‘Jardiance’ for type 2 diabetes and underwent amputation of toes, feet, or legs, contact our national firm today by calling 1-800-YOURLAWYER (1-800-968-7529) or by filling out our online form.
